6533b821fe1ef96bd127ae93

RESEARCH PRODUCT

Multiplex Amplicon Quantification (MAQ), a fast and efficient method for the simultaneous detection of copy number alterations in neuroblastoma

Jurgen Del-faveroKatleen De PreterFrank SpelemanNadine Van RoyDirk GoossensJo VandesompeleRosa NogueraCandy KumpsLien Heyrman

subject

lcsh:QH426-470DNA Copy Number Variationslcsh:BiotechnologyCopy number analysisARRAY CGHBiologyProteomicsGenomePolymerase Chain Reactionlaw.inventionNeuroblastomalawlcsh:TP248.13-248.65GeneticsMedicine and Health SciencesHumansSUBGROUPSMultiplexBiologyPolymerase chain reactionDEMENTIANucleic acid amplification techniqueAmpliconMolecular biologylcsh:GeneticsHuman medicineDNA microarrayNucleic Acid Amplification TechniquesBiotechnologyResearch Article

description

Abstract Background Cancer genomes display characteristic patterns of chromosomal imbalances, often with diagnostic and prognostic relevance. Therefore assays for genome-wide copy number screening and simultaneous detection of copy number alterations in specific chromosomal regions are of increasing importance in the diagnostic work-up of tumors. Results We tested the performance of Multiplex Amplicon Quantification, a newly developed low-cost, closed-tube and high-throughput PCR-based technique for detection of copy number alterations in regions with prognostic relevance for neuroblastoma. Comparison with array CGH and the established Multiplex Ligation-dependent Probe Amplification method on 52 neuroblastoma tumors showed that Multiplex Amplicon Quantification can reliably detect the important genomic aberrations. Conclusion Multiplex Amplicon Quantification is a low-cost and high-throughput PCR-based technique that can reliably detect copy number alterations in regions with prognostic relevance for neuroblastoma.

10.1186/1471-2164-11-298https://hdl.handle.net/1854/LU-1004298